<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04650750</url>
  </required_header>
  <id_info>
    <org_study_id>CMRPG1J0131</org_study_id>
    <nct_id>NCT04650750</nct_id>
  </id_info>
  <brief_title>The Treatment Effect of Chinese Medicine Formula on Uremic Pruritus</brief_title>
  <official_title>The Treatment Effect of Chinese Medicine Formula on Uremic Pruritus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of hemodialysis patients is increasing in recent years. And the uremic&#xD;
      pruritus is a common and bothersome symptom among the patients. Current therapies for uremic&#xD;
      pruritus, including dialysis modification, topical treatment such as emollients and topical&#xD;
      analgesic agent, phototherapy, acupuncture, and gabapentin. However, the efficacy of these&#xD;
      treatments remains poorly defined.&#xD;
&#xD;
      In our experiment, the investigators tried to find an effective way to control uremic&#xD;
      pruritus through Chinese traditional medicine.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence of hemodialysis patients is increasing in recent years. And the uremic&#xD;
      pruritus is a common and bothersome symptom among the patients. Current therapies for uremic&#xD;
      pruritus, including dialysis modification, topical treatment such as emollients and topical&#xD;
      analgesic agent, phototherapy, acupuncture, and gabapentin. However, the efficacy of these&#xD;
      treatments remains poorly defined.&#xD;
&#xD;
      In our experiment, the investigators tried to find an effective way to control uremic&#xD;
      pruritus through Chinese traditional medicine. &quot;Xiao-Feng-San&quot; is a common Chinese herbal&#xD;
      preparation, composed of 13 herbs, which is used to treat patients with dermatitis. The&#xD;
      component of &quot;Xiao-Feng-San&quot; has immunomodulatory activity. &quot;Shian Fang Hwa Ming Yiin&quot; is&#xD;
      another common Chinese herbal preparation, composed of 12 herbs, which is used to treat&#xD;
      patients with carbuncles and acne. The component of &quot;Shian Fang Hwa Ming Yiin&quot; has&#xD;
      anti-inflammation and anti-microbial effect.&#xD;
&#xD;
      The purpose of this study is to evaluate the treatment effect of Xiao-Feng-San and Shian Fang&#xD;
      Hwa Ming Yiin on uremic pruritus among hemodialysis patients in this randomized,&#xD;
      double-blind, placebo-controlled study design.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale(VAS)</measure>
    <time_frame>on starting day (day 0)</time_frame>
    <description>Measuring itch intensity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogue Scale(VAS)</measure>
    <time_frame>on day 28</time_frame>
    <description>Measuring itch intensity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogue Scale(VAS)</measure>
    <time_frame>on day 56</time_frame>
    <description>Measuring itch intensity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogue Scale(VAS)</measure>
    <time_frame>on day 84</time_frame>
    <description>Measuring itch intensity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>5-D itch scale</measure>
    <time_frame>on starting day (day 0)</time_frame>
    <description>(1) duration of itchiness, (2) degree of itchiness, (3) direction of itchiness, (4) disability caused by itchiness, and (5) distribution of itchiness</description>
  </primary_outcome>
  <primary_outcome>
    <measure>5-D itch scale</measure>
    <time_frame>on day 28</time_frame>
    <description>(1) duration of itchiness, (2) degree of itchiness, (3) direction of itchiness, (4) disability caused by itchiness, and (5) distribution of itchiness</description>
  </primary_outcome>
  <primary_outcome>
    <measure>5-D itch scale</measure>
    <time_frame>on day 56</time_frame>
    <description>(1) duration of itchiness, (2) degree of itchiness, (3) direction of itchiness, (4) disability caused by itchiness, and (5) distribution of itchiness</description>
  </primary_outcome>
  <primary_outcome>
    <measure>5-D itch scale</measure>
    <time_frame>on day 84</time_frame>
    <description>(1) duration of itchiness, (2) degree of itchiness, (3) direction of itchiness, (4) disability caused by itchiness, and (5) distribution of itchiness</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Uremic Pruritus</condition>
  <arm_group>
    <arm_group_label>Xiao-Feng-San; Shian-Fang-Hwa-Ming-Yiin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Xiao-Feng-San 2g+ Shian Fang Hwa Ming Yiin 2g; twice a day for two months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Similar placebo 4g twice a day for two months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xiao-Feng-San+Shian-Fang-Hwa-Ming-Yiin</intervention_name>
    <description>&quot;Xiao-Feng-San&quot; is a common Chinese herbal preparation, composed of 13 herbs, which is used to treat patients with dermatitis. The component of &quot;Xiao-Feng-San&quot; has immunomodulatory activity. &quot;Shian Fang Hwa Ming Yiin&quot; is another common Chinese herbal preparation, composed of 12 herbs, which is used to treat patients with carbuncles and acne. The component of &quot;Shian Fang Hwa Ming Yiin&quot; has anti-inflammation and anti-microbial effect.</description>
    <arm_group_label>Xiao-Feng-San; Shian-Fang-Hwa-Ming-Yiin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Similar placebo 4g twice a day for two months</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. At least 3 episodes of itch during 2 weeks or less, the itch occurring several times a&#xD;
             day, lasting for more than 5 min and being bothersome&#xD;
&#xD;
          2. An intermittent itch over a period of 6 months or more, with a clinical appearance,&#xD;
             but with a lower frequency than in (1)&#xD;
&#xD;
          3. People with clear consciousness, without cognitive impairment&#xD;
&#xD;
          4. Those who can cooperate to fill in relevant questionnaires&#xD;
&#xD;
          5. Willing to sign consent forms&#xD;
&#xD;
          6. Blood test indicators: (1) Intact parathyroid hormone (iPTH) &lt;600 pg/ml (2) Kt/V &gt;1.2&#xD;
             (3) Serum phosphate &lt;6 mg/dl&#xD;
&#xD;
          7. Refractory uremic pruritus; The patient failed to respond to following treatments (1)&#xD;
             avoiding food containing high amounts of phosphate (2) haemodialysis with a dialysate&#xD;
             containing 3.0 or 2.5 mEq/l of calcium (3) changing the dialyser or increasing blood&#xD;
             flow&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Be younger than 20 years old.&#xD;
&#xD;
          2. People suffering from diagnosed skin diseases (scabies, drug allergy, atopic&#xD;
             dermatitis), severe infections, liver failure, blood diseases or biliary diseases.&#xD;
&#xD;
          3. Patients with abnormal liver and kidney function.&#xD;
&#xD;
          4. People suffering from cognitive dysfunction caused by neurological diseases or mental&#xD;
             diseases.&#xD;
&#xD;
          5. People with severe visual impairment, hearing impairment, and physical impairment that&#xD;
             affect the scale test.&#xD;
&#xD;
          6. Those who are undergoing other trials.&#xD;
&#xD;
          7. Those who are pregnant or breastfeeding.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jiun-Liang Chen, Ph.D</last_name>
    <phone>+88633196200</phone>
    <phone_ext>2611</phone_ext>
    <email>a12015@adm.cgmh.org.tw</email>
  </overall_contact>
  <reference>
    <citation>Mathur VS, Lindberg J, Germain M, Block G, Tumlin J, Smith M, Grewal M, McGuire D; ITCH National Registry Investigators. A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol. 2010 Aug;5(8):1410-9. doi: 10.2215/CJN.00100110. Epub 2010 Jun 17.</citation>
    <PMID>20558560</PMID>
  </reference>
  <reference>
    <citation>Rayner HC, Larkina M, Wang M, Graham-Brown M, van der Veer SN, Ecder T, Hasegawa T, Kleophas W, Bieber BA, Tentori F, Robinson BM, Pisoni RL. International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis. Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2000-2007. doi: 10.2215/CJN.03280317. Epub 2017 Sep 18.</citation>
    <PMID>28923831</PMID>
  </reference>
  <reference>
    <citation>Kuypers DR. Skin problems in chronic kidney disease. Nat Clin Pract Nephrol. 2009 Mar;5(3):157-70. doi: 10.1038/ncpneph1040. Epub 2009 Feb 3. Review.</citation>
    <PMID>19190625</PMID>
  </reference>
  <reference>
    <citation>Szepietowski JC, Morita A, Tsuji T. Ultraviolet B induces mast cell apoptosis: a hypothetical mechanism of ultraviolet B treatment for uraemic pruritus. Med Hypotheses. 2002 Feb;58(2):167-70.</citation>
    <PMID>11812197</PMID>
  </reference>
  <reference>
    <citation>Kim KH, Lee MS, Choi SM. Acupuncture for treating uremic pruritus in patients with end-stage renal disease: a systematic review. J Pain Symptom Manage. 2010 Jul;40(1):117-25. Review.</citation>
    <PMID>21796811</PMID>
  </reference>
  <reference>
    <citation>Okada K, Matsumoto K. Effect of skin care with an emollient containing a high water content on mild uremic pruritus. Ther Apher Dial. 2004 Oct;8(5):419-22.</citation>
    <PMID>15663539</PMID>
  </reference>
  <reference>
    <citation>Young TA, Patel TS, Camacho F, Clark A, Freedman BI, Kaur M, Fountain J, Williams LL, Yosipovitch G, Fleischer AB Jr. A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients. J Dermatolog Treat. 2009;20(2):76-81. doi: 10.1080/09546630802441218.</citation>
    <PMID>18821119</PMID>
  </reference>
  <reference>
    <citation>Tarng DC, Cho YL, Liu HN, Huang TP. Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream. Nephron. 1996;72(4):617-22.</citation>
    <PMID>8730431</PMID>
  </reference>
  <reference>
    <citation>Russo GE, Spaziani M, Guidotti C, Scarpellini MG, Leri O, Bonini S, Crisciotti C, Carmenini G. [Pruritus in chronic uremic patients in periodic hemodialysis. Treatment with terfenadine (an antagonist of histamine H1 receptors)]. Minerva Urol Nefrol. 1986 Oct-Dec;38(4):443-7. Italian.</citation>
    <PMID>2884733</PMID>
  </reference>
  <reference>
    <citation>Rayner H, Baharani J, Smith S, Suresh V, Dasgupta I. Uraemic pruritus: relief of itching by gabapentin and pregabalin. Nephron Clin Pract. 2012;122(3-4):75-9. doi: 10.1159/000349943. Epub 2013 Mar 28.</citation>
    <PMID>23548570</PMID>
  </reference>
  <reference>
    <citation>Simonsen E, Komenda P, Lerner B, Askin N, Bohm C, Shaw J, Tangri N, Rigatto C. Treatment of Uremic Pruritus: A Systematic Review. Am J Kidney Dis. 2017 Nov;70(5):638-655. doi: 10.1053/j.ajkd.2017.05.018. Epub 2017 Jul 15. Review.</citation>
    <PMID>28720208</PMID>
  </reference>
  <reference>
    <citation>Cheng HM, Chiang LC, Jan YM, Chen GW, Li TC. The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Int Arch Allergy Immunol. 2011;155(2):141-8. doi: 10.1159/000318861. Epub 2010 Dec 22.</citation>
    <PMID>21196758</PMID>
  </reference>
  <reference>
    <citation>Chen HY, Lin YH, Chen YC. Identifying Chinese herbal medicine network for treating acne: Implications from a nationwide database. J Ethnopharmacol. 2016 Feb 17;179:1-8. doi: 10.1016/j.jep.2015.12.032. Epub 2015 Dec 22.</citation>
    <PMID>26721214</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 28, 2020</study_first_submitted>
  <study_first_submitted_qc>November 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2020</study_first_posted>
  <last_update_submitted>November 25, 2020</last_update_submitted>
  <last_update_submitted_qc>November 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Uremic pruritus; Hemodialysis; Chinese medicine; Xiao-Feng-San; Shian Fang Hwa Ming Yiin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pruritus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

